Viewing Study NCT02927405


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2025-12-26 @ 1:52 AM
Study NCT ID: NCT02927405
Status: WITHDRAWN
Last Update Posted: 2021-05-25
First Post: 2016-10-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain
Sponsor: State University of New York - Downstate Medical Center
Organization:

Study Overview

Official Title: Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain
Status: WITHDRAWN
Status Verified Date: 2021-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Did not get the study to take off, did not recruit any subjects, and then closed the study.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: There is an increasing trend on decreasing narcotic use and maximizing efficiency in the perioperative care. There are no studies that have compared a TAP block versus a TAP block plus gabapentin for laparoscopic procures.This study will investigate if taking gabapentin and receiving a TAP block decrease post-operative morphine consumption. It will be a randomized controlled, double blind study, with 130 patients between 18-60 years; that will undergo laparoscopic GYN procedures. Secondary outcomes will look at the incidence of nausea, vomiting, and VAS (verbal analog scale) scores. This combination may be helpful because gabapentin will be used to decrease visceral and central pain, and TAP block will decrease somatic pain. Performing a multimodal approach may decrease narcotic consumption, adverse effects and improve pain management.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: